Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Capital Expenditures (2016 - 2022)

RedHill Biopharma has reported Capital Expenditures over the past 11 years, most recently at -$22000.0 for Q3 2022.

  • Quarterly Capital Expenditures fell 4.76% to -$22000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$198000.0 through Dec 2022, down 72.17% year-over-year, with the annual reading at -$5000.0 for FY2025, 44.44% up from the prior year.
  • Capital Expenditures was -$22000.0 for Q3 2022 at RedHill Biopharma, up from -$163000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at -$1000.0 in Q3 2019 and troughed at -$242000.0 in Q1 2020.
  • The 5-year median for Capital Expenditures is -$20000.0 (2020), against an average of -$51631.6.
  • Year-over-year, Capital Expenditures skyrocketed 98.04% in 2018 and then tumbled 16500.0% in 2020.
  • A 5-year view of Capital Expenditures shows it stood at -$5000.0 in 2018, then crashed by 560.0% to -$33000.0 in 2019, then tumbled by 48.48% to -$49000.0 in 2020, then soared by 93.88% to -$3000.0 in 2021, then plummeted by 633.33% to -$22000.0 in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Capital Expenditures are -$22000.0 (Q3 2022), -$163000.0 (Q2 2022), and -$13000.0 (Q1 2022).